Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suppressor cell function in solid tumor cancer patients.

× No keyword cloud information.

11 in total

1. Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.

Authors: L A Santana-Blank; M Castes; M E Rojas; F Vargas; D Scott-Algara
Journal: Clin Exp Immunol Date: 1992-10 Impact factor: 4.330

2. Modulation of in vitro antitumor immunity in response to the biological activators interleukin-2, gamma interferon, and granulocyte monocyte-colony stimulating factor in the peripheral blood of cancer patients receiving cytotoxic chemotherapy.

Authors: J E Harris; D P Braun
Journal: Bull N Y Acad Med Date: 1989-01

3. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.

Authors: N Lahat; B Alexander; D R Levin; B Moskovitz
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

Review 4. The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors: I M Svane; M Boesen; A M Engel
Journal: Med Oncol Date: 1999-12 Impact factor: 3.064

5. Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.

Authors: J Richner; E P Ambinder; K Hoffmann; E J Feuer; G Bekesi
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

6. Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.

Authors: K Höbarth; A Hallas; G Steiner; A Gomahr; W Aulitzky; M Marberger
Journal: Urol Res Date: 1996

7. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).

Authors: Leonard Christopher Schmeel; Frederic Carsten Schmeel; Christoph Coch; Ingo G H Schmidt-Wolf
Journal: J Cancer Res Clin Oncol Date: 2014-11-08 Impact factor: 4.553

8. Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?

Authors: S H Lim; C P Worman; A H Goldstone
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

9. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.

Authors: J Vibe-Petersen; N Tvede; M Diamant; A A Kjerulff; H R Sørensen; V Andersen
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

10. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.

Authors: Liangrong Shi; Qi Zhou; Jun Wu; Mei Ji; Guojun Li; Jingting Jiang; Changping Wu
Journal: Cancer Immunol Immunother Date: 2012-06-07 Impact factor: 6.968